المؤلفون: Purmonen T, Puolakka K, Mishra D, Gunda P, Martikainen J

المصدر: ClinicoEconomics and Outcomes Research, Vol Volume 11, Pp 159-168 (2019)

مصطلحات موضوعية: Ankylosing Spondylitis, Secukinumab, Cost-effectiveness, Finland, Medicine (General), R5-920, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/cost-effectiveness-of-secukinumab-compared-to-other-biologics-in-the-t-peer-reviewed-article-CEORTest; https://doaj.org/toc/1178-6981Test

الوصول الحر: https://doaj.org/article/eb2b8b2a950c43b0b4b1788afe0335b5Test

المؤلفون: Kyllönen, M. S. (Minna S.), Ebeling, H. (Hanna), Kautiainen, H. (Hannu), Puolakka, K. (Kari), Vähäsalo, P. (Paula)

مصطلحات موضوعية: Chronic illness, Juvenile idiopathic arthritis, Mental health, Psychiatric disorders

وصف الملف: application/pdf

الإتاحة: http://urn.fi/urn:nbn:fi-fe2021081743457Test

المؤلفون: Keinänen, M. (Mika), Brummer-Korvenkontio, H. (Henrikki), Eskola, M. (Markku), Ettala, O. (Otto), Hartikainen, J. (Juha), Hovi, P. (Petteri), Isosomppi, S. (Sanna), Kivelä, P. (Pia), Kärki, J. (Johanna), Kärkkäinen, J. (Jukka), Laatikainen, T. (Tiina), Liukko, E. (Emmi), Niemi, A. (Anu), Mattila, E. (Elina), Meriläinen, M. (Merja), Mustonen, P. (Pirjo), Pekkanen, L. (Liisa), Puolakka, K. (Kari), Relas, H. (Heikki), Sainio, S. (Salla), Salo, H. (Henri), Salonen, J. (Jonna), Sokka-Isler, T. (Tuulikki), Suvisaari, J. (Jaana), Tahkola, A. (Aapo), Tiirinki, H. (Hanna), Vähäsalo, P. (Paula), Malmivaara, A. (Antti)

وصف الملف: application/pdf

الإتاحة: http://urn.fi/urn:nbn:fi-fe2021081743467Test

المؤلفون: Muilu, P., Rantalaiho, V., Kautiainen, H., Virta, L.J., Puolakka, K.

المصدر: THURSDAY, 14 JUNE 2018

الإتاحة: https://doi.org/10.1136/annrheumdis-2018-eular.4270Test

المؤلفون: Purmonen, T, Puolakka, K, Bhattacharyya, D, Jain, M, Martikainen, J

المساهمون: School of Pharmacy, Activities

مصطلحات موضوعية: psoriatic arthritis, cost-effectiveness, biologics, secukinumab, incremental cost effectiveness ratio, quality adjusted life years

العلاقة: Cost effectiveness and resource allocation; http://dx.doi.org/10.1186/s12962-018-0162-3Test; 56; 16; https://erepo.uef.fi/handle/123456789/7277Test

الإتاحة: https://doi.org/10.1186/s12962-018-0162-3Test
https://erepo.uef.fi/handle/123456789/7277Test

المؤلفون: Muilu, P, Rantalaiho, V, Kautiainen, H, Virta, L, Puolakka, K

المصدر: Poster Presentations

الإتاحة: https://doi.org/10.1136/annrheumdis-2017-eular.2027Test

المؤلفون: Kyllonen, M, Kautiainen, H, Puolakka, K, Vahasalo, P

المصدر: Poster Presentations

الإتاحة: https://doi.org/10.1136/annrheumdis-2017-eular.4042Test

المؤلفون: Laine J, Jokiranta TS, Eklund KK, Väkeväinen M, Puolakka K

المصدر: Biologics: Targets & Therapy, Vol 2016, Iss Issue 1, Pp 67-73 (2016)

مصطلحات موضوعية: TNF blockers, anti-drug antibodies, drug concentration, Medicine (General), R5-920

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/cost-effectiveness-of-routine-measuring-of-serum-drug-concentrations-a-peer-reviewed-article-BTTTest; https://doaj.org/toc/1177-5491Test

الوصول الحر: https://doaj.org/article/0445bfa0021849d5b207becc33be2a18Test

المؤلفون: Elfving, P., Puolakka, K., Kautiainen, H., Virta, L. J., Pohjolainen, T., Kaipiainen-Seppanen, O.

المساهمون: Department of General Practice and Primary Health Care, Clinicum

مصطلحات موضوعية: Systemic lupus erythematosus, medication, drug, register, INCEPTION COHORT, TASK-FORCE, DISEASE, ATHEROSCLEROSIS, ADHERENCE, HYDROXYCHLOROQUINE, RECOMMENDATIONS, MEDICATIONS, PREVALENCE, STRATEGIES, 3121 General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

العلاقة: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was supported by grants from the Finnish Cultural Foundation, North Savo Regional fund and the Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding.; Elfving , P , Puolakka , K , Kautiainen , H , Virta , L J , Pohjolainen , T & Kaipiainen-Seppanen , O 2016 , ' Drugs used in incident systemic lupus erythematosus - results from the Finnish nationwide register 2000-2007 ' , Lupus , vol. 25 , no. 6 , pp. 666-670 . https://doi.org/10.1177/0961203316628998Test; 84963543345; 6851bccb-bbd6-49c3-bfec-d7ac391623be; http://hdl.handle.net/10138/223949Test; 000374053800013

الإتاحة: http://hdl.handle.net/10138/223949Test

المؤلفون: Huoponen, S, Aaltonen, KJ, Joensuu, JT, Rutanen, J, Relas, H, Taimen, K, Puolakka, K, Sokka, T, Nordström, D, Blom, M

المصدر: Value in Health ; volume 19, issue 7, page A538 ; ISSN 1098-3015

مصطلحات موضوعية: Public Health, Environmental and Occupational Health, Health Policy

الإتاحة: https://doi.org/10.1016/j.jval.2016.09.1110Test
https://api.elsevier.com/content/article/PII:S1098301516324767?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1098301516324767?httpAccept=text/plainTest